z-logo
Premium
HemoCD as a Totally Synthetic Artificial Oxygen Carrier: Improvements in the Synthesis and O 2 /CO Discrimination
Author(s) -
Kitagishi Hiroaki,
Mao Qiyue,
Kitamura Naoya,
Kita Takahiro
Publication year - 2017
Publication title -
artificial organs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.684
H-Index - 76
eISSN - 1525-1594
pISSN - 0160-564X
DOI - 10.1111/aor.12870
Subject(s) - porphyrin , chemistry , dimer , selectivity , pyridine , yield (engineering) , oxygen , carboxylate , aqueous solution , linker , combinatorial chemistry , hemoglobin , stereochemistry , photochemistry , medicinal chemistry , organic chemistry , materials science , catalysis , computer science , metallurgy , operating system
HemoCD, which is composed of an iron(II)porphyrin such as 5,10,15,20‐tetrakis(4‐sulfonatophenyl)porphinatoiron(II) (Fe(II)TPPS) and a cyclodextrin (CD) dimer having a pyridine linker, represents a synthetic hemoglobin (Hb) model compound that exhibits reversible oxygen (O 2 ) binding ability in aqueous solution at an ambient temperature. Therefore, hemoCD has the potential to be used as a totally synthetic artificial oxygen carrier. In this article, we describe the improvements of hemoCD related to its synthesis and O 2 /CO selectivity. The synthesis procedure of the CD dimer of hemoCD was re‐examined, and the CD dimer was successively synthesized from inexpensive β‐CD with a 38% yield (three‐steps), which enabled us to obtain the CD dimer in gram‐quantities. The O 2 /CO selectivity of hemoCD was also markedly improved using an iron(II)porphyrin having a carboxylate group at the distal site of hemoCD.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom